RESUMO
Objective: Somatic symptoms are one of the most prevalent complaints in both psychiatric and general population, and validated scales are required to assess these problems. The present study was conducted to determine psychometric properties of the Persian version of Screening for Somatic Symptom Disorders-7(SOMS-7) in an Iranian population. Method : This was a multi centric comprehensive study conducted in Psychosomatic Research Center of Isfahan University of Medical Sciences in collaboration with Department of Clinical Psychology of Philipp University of Marburg, Germany. This part of the study includes 100 patients with anxiety/mood disorders and 291 healthy individuals. All participants completed the Patient Health Questionnaire (PHQ-15) and Screening for Somatic symptom disorders 7(SOMS-7). Data were analyzed by Pearson and Spearman correlation coefficient, factor analysis, independent t test, and discriminant analysis using SPSS-20 software. Results: Reliability coefficient based on Cronbach's alpha was 0.92 and 0.94 (clinical vs. healthy sample). Validity index of the SOMS according to correlation between factor 1 and 2 with PHQ somatic subscale was. 51 and. 59, respectively. Score of 15.5 as cut-off point was accompanied with sensitivity of 77% and specificity of 66%. Factor analysis extracted 2 factors in patients and 4 factors in healthy population. Conclusion: Findings of this study indicated that the Persian version of SOMS-7 has appropriate reliability and validity for the assessment of somatic symptoms disorder and evaluation of treatment effects in these patients.
RESUMO
BACKGROUND: Dairy products intolerance is defined by existing of gastrointestinal symptoms following dairy product consumption. Its prevalence varies among different countries. This study is conducted to determine the frequencies and severities of intolerance symptoms in the consumption of different dairy products in Iranian students of Medical Sciences. METHODS: In this cross-sectional study, 1041 students from Isfahan University of Medical Sciences who apparently were healthy and had not used any drug before, participated. The questionnaire included information about dairy product consumption and avoidance, severity of dairy intolerance symptoms included gas passing, flatulence, diarrhea and abdominal pain and coexistence of irritable bowel syndrome (IBS) RESULTS: The frequencies of dairy intolerance syndromes in milk, yoghurt, cheese and ice cream consumption were 51.1% (532), 16.6% (173), 11.7% (122) and 13.4% (140), respectively. Most severe symptoms for milk, yoghurt, cheese and ice cream intolerance were diarrhea (2.11 ± 0.08), gas passing (1.56 ± 0.09) and flatulence (1.49 ± 0.09), respectively. Fifty (9.4%) of symptomatic respondents never drank milk. Correlation coefficient between symptoms severity and the avoidance of consumption in milk intolerance was 0.38. CONCLUSIONS: Students tolerate other dairy products better in comparison with milk. In the present study, the phenomenon as irritable bowel syndrome was not strongly associated with the severity of all symptoms in dairy intolerant persons. Also, there were weak association between the severity of symptoms with dairy consumption and avoidance, but more studies are needed to evaluate calcium absorption and osteoporosis in symptomatic cases.